Tag: $Verve Therapeutics

Lilly to buy gene-editing partner Verve for up to $1.3 billion in cardiac care push

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs.